Nobiletin attenuates doxorubicin-induced cardiotoxicity by promoting pyruvate kinase M2 tetramerization.
- DOI
- 10.1016/j.ejphar.2026.179301
- Published
- 2026 Sep 9
- Container
- European journal of pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejphar.2026.179301,
title = {Nobiletin attenuates doxorubicin-induced cardiotoxicity by promoting pyruvate kinase M2 tetramerization.},
author = {Dai X and Tang M and Wu Y and Yu J and Zou X and Lin D and Xu H},
year = {2026},
journal = {European journal of pharmacology},
doi = {10.1016/j.ejphar.2026.179301},
url = {https://doi.org/10.1016/j.ejphar.2026.179301}
}RIS
TY - JOUR TI - Nobiletin attenuates doxorubicin-induced cardiotoxicity by promoting pyruvate kinase M2 tetramerization. AU - Dai X AU - Tang M AU - Wu Y AU - Yu J AU - Zou X AU - Lin D AU - Xu H PY - 2026 JO - European journal of pharmacology DO - 10.1016/j.ejphar.2026.179301 UR - https://doi.org/10.1016/j.ejphar.2026.179301 ER -
APA
X, D., M, T., Y, W., J, Y., X, Z., D, L., & H, X. (2026). Nobiletin attenuates doxorubicin-induced cardiotoxicity by promoting pyruvate kinase M2 tetramerization.. European journal of pharmacology. https://doi.org/10.1016/j.ejphar.2026.179301
Source records
- pubmed · retrieved 2026-09-25T07:47:48.502Z